A new study uncovers how melanomas can arise from minimal genetic changes, shedding light on the early, often elusive steps ...

New Combination Drug Therapy Shows Promise for Advanced Melanoma PatientsThe Mountain West has the one of the highest rates of melanoma in the nation ...

Welcome to the second installment of "Cancer and the Gut Microbiome: A Miniseries". Here, we focus on how the microbiome ...

Researchers led by John T. Wilson, Vanderbilt University associate professor of chemical and biomolecular engineering and ...

Eight researchers specializing in adult oncology from Fred Hutch Cancer Center and the University of Washington have been ...

Researchers at VCU Massey Comprehensive Cancer Center and the VCU Institute of Molecular Medicine (VIMM) have discovered a ...

The anti-CCR8 antibodies market holds potential in addressing unmet needs across inflammatory and cancerous diseases. The ...

Program highlights for the fiscal year ended March 31, 2025, along with recent developments, include: Patient with advanced/metastatic end-stage pancreatic cancer who responded to MDNA11 treatment ...

MDNA11 Phase 1/2 clinical trial on track for data readouts in second half of the year as a single agent and in combination with KEYTRUDA® ...

While artificial intelligence (AI) holds promise to improve the diagnosis of melanoma, researchers of a new review outlined ...

Research led by the National Institute of Biological Sciences in Beijing has discovered that switching on a single dormant ...